Indication
Acute respiratory distress syndrome
1 clinical trial
2 products
Clinical trial
Phase 2 Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients With Respiratory Distress Due to COVID-19 InfectionStatus: Terminated, Estimated PCD: 2022-05-10
Product
PlaceboProduct
USB002